Thermo Fisher to sell microbiology business to PE firm Astorg for over $1 billion
Summary
Thermo Fisher expects the deal to be dilutive to adjusted earnings per share by $0.15 in the first full year after it closes.
Description
Thermo Fisher expects the deal to be dilutive to adjusted earnings per share by $0.15 in the first full year after it closes.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source